Last A$1.01 AUD
Change Today 0.00 / 0.00%
Volume 0.0
VSC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 9:41 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

vita life sciences ltd (VSC) Snapshot

Open
A$1.01
Previous Close
A$1.01
Day High
A$1.01
Day Low
A$1.01
52 Week High
04/2/13 - A$1.50
52 Week Low
05/24/12 - A$0.36
Market Cap
56.9M
Average Volume 10 Days
119.1K
EPS TTM
A$0.04
Shares Outstanding
56.4M
EX-Date
03/8/13
P/E TM
23.9x
Dividend
A$0.01
Dividend Yield
1.39%
Current Stock Chart for VITA LIFE SCIENCES LTD (VSC)

Related News

No related news articles were found.

vita life sciences ltd (VSC) Related Businessweek News

No Related Businessweek News Found

vita life sciences ltd (VSC) Details

Vita Life Sciences Limited engages in formulating, packaging, selling, and distributing vitamins and supplements primarily in Australia, Singapore, and Malaysia. It offers a range of supplements, vitamins, minerals, meal replacement, sports nutrition, and herbals for men, women, and children; and over the counter products. The company markets its products through pharmacies and health food stores primarily under the VitaHealth and Herbs of Gold brand names. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.

350 Employees
Last Reported Date: 03/26/13
Founded in 1947

vita life sciences ltd (VSC) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: A$124.3K
President of Multi-Level Marketing
Total Annual Compensation: A$150.6K
Senior General Manager of Asian Business and ...
Total Annual Compensation: A$185.6K
Compensation as of Fiscal Year 2012.

vita life sciences ltd (VSC) Key Developments

Vita Life Sciences Limited, Annual General Meeting, May 23, 2013

Vita Life Sciences Limited, Annual General Meeting, May 23, 2013., at 14:00 AUS Eastern Standard Time. Location: Level 1, St Kilda Road Towers. Agenda: To approve Financial Statements and remuneration Reports; to approve re-election of Directors; to approve share buy-back; to approve long term incentive plan: Amendment to terms of limited recourse loan to Managing Director to purchase ordinary shares; to approve long term incentive plan: Amendment of terms of limited recourse loan to Director of Subsidiary to purchase ordinary shares; and to approve other business.

Vita Life Sciences Limited Reports Earnings Results for the Year Ended December 31, 2012; Declares Final Dividend, Payable on March 28, 2013; Provides Earnings Guidance for the Fiscal Year 2013

Vita Life Sciences Limited reported earnings results for the year ended December 31, 2012. For the year, the company's revenue was $30.191 million compared with $24.267 million a year ago. EBIT was $2.865 million compared with $1.489 million a year ago. Profit before tax was $2.841 million compared with $1.403 million a year ago. Profit after tax was $2.316 million or 4.14 cents per share compared with $1.213 million or 2.12 cents per share a year ago. EBITDA was $2.87 million compared with $1.49 million a year ago. Operating cash flows were $1.38 million compared with $5.66 million a year ago. The company declared final dividend of 0.5 cent per share for the year ended December 31, 2012. Total dividend for the financial year was 1.0 cent per share. The dividend will be payable on March 28, 2013 to the shareholders of record on March 15, 2013. The ex-dividend date is March 8, 2013. Barring unforeseen circumstances, the company is targeting a 40% to 50% increase in EBIT in the fiscal year 2013.

Vita Life Sciences Limited to Report Fiscal Year 2012 Results on Feb 28, 2013

Vita Life Sciences Limited announced that they will report fiscal year 2012 results on Feb 28, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSC:AU A$1.01 AUD 0.00

VSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VSC.
View Industry Companies
 

Industry Analysis

VSC

Industry Average

Valuation VSC Industry Range
Price/Earnings 23.0x
Price/Sales 1.7x
Price/Book 4.8x
Price/Cash Flow 22.7x
TEV/Sales 1.6x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITA LIFE SCIENCES LTD, please visit www.vitalifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.